No Data
No Data
As of May 31, 2024, the number of shareholders of Anhui Fengyuan Pharmaceutical (000153.SZ) was 38,682.
Anhui Fengyuan Pharmaceutical (000153.SZ) stated on the investor interaction platform that as of May 31, 2024, the number of shareholders in the company was 38682.
There's A Lot To Like About Anhui Fengyuan Pharmaceutical's (SZSE:000153) Upcoming CN¥0.15 Dividend
Anhui Fengyuan Pharmaceutical Co., Ltd. (SZSE:000153) is about to trade ex-dividend in the next three days. The ex-dividend date is usually set to be one business day before the record date which is
Fengyuan Pharmaceutical (000153.SZ): 2023 equity distribution of 10 to 4 transfers of 1.5 yuan share registration date June 6
Gelonghui, May 29丨Fengyuan Pharmaceutical (000153.SZ) announced that the company's 2023 equity distribution plan is to distribute RMB 1.5 in cash (tax included) to all shareholders for every 10 shares based on the company's current total share capital of 332,026,230 shares. At the same time, the capital reserve fund will be used to transfer 4 shares for every 10 shares to all shareholders. The share registration date for this equity distribution is June 6, 2024, and the ex-dividend date is June 7, 2024.
Fengyuan Pharma Gets Nod to Register Two Dialysis Solutions
Chinese drug regulator National Medical Products Administration granted drug registration certificates to two of Anhui Fengyuan Pharmaceutical's (SHE:000153) dialysis solutions, the company said in it
Fengyuan Pharmaceutical (000153.SZ) obtained two drug registration certificates
Fengyuan Pharmaceutical (000153.SZ) announced that the company received approval from the State Drug Administration for low calcium peritoneal penetration...
Fengyuan Pharmaceutical (000153.SZ): Low calcium peritoneal dialysis solution (lactate-G 1.5%) and low calcium peritoneal dialysis solution (lactate-G 2.5%) obtained drug registration certificates
Gelonghui, May 10, 丨 Fengyuan Pharmaceutical (000153.SZ) announced that recently, the company received the “Drug Registration Certificate” (certificate number: 2024S00742) for the low-calcium peritoneal dialysate (lactate-G 2.5%) and the “Drug Registration Certificate” (certificate number: 2024S00741) and low-calcium peritoneal dialysis solution (lactate-G 1.5%) approved and issued by the State Drug Administration.
No Data